“…It has advantages of deep penetration, minimal invasion, repeatable operation, and low interference from bone and gas. − However, high microwave (MW) radiation energy that can kill tumor cells usually causes significant injury to adjacent normal tissues within the radiation range due to its nonselective nature . Moreover, residual sporadic lesions often still exist after MWTT, , and the infiltration of predominant myeloid suppressor cells (e.g., myeloid-derived suppressor cells (MDSCs)) in these residual lesions will be increased to induce the generation of immunosuppression, making tumor prone to recurrence and metastasis. , To date, a variety of MW thermal sensitizers, mainly including inorganic and organic–inorganic hybrid nanoparticles, have been successfully developed for enhancing MW heating at tumor sites and reducing the induced MW thermal damage to adjacent tissues. − Multiple expanded strategies based on these MW thermal sensitizers have also been widely proposed with an attempt to achieve more comprehensive tumor suppression, for example, combining an MW sensitizer with chemotherapeutic drugs to construct an integrated platform for MW thermal sensitization and drug delivery , or endowing an MW thermal sensitizer with dynamic sensitization characteristics simultaneously to realize MW dynamic therapy-assisted MWTT. − Although the temporary inhibitory effect has been extremely improved, the long-term antitumor outcomes are still disappointing, remaining the main obstacles impeding the further development of MWTT. Hence, weakening or even abolishing the immunosuppression after MWTT and further activating antitumor immune response for achieving long-lasting tumor inhibition will be of great importance.…”